Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-09 08:44 am Sale | 2022-02-28 | 13G | Emergent BioSolutions Inc. EBS | VANGUARD GROUP INC | 5,352,952 10.600% | -9,079 (-0.17%) | Filing History |
| 2022-02-11 3:59 pm Sale | 2021-12-31 | 13G | Emergent BioSolutions Inc. EBS | NEUBERGER BERMAN GROUP LLC | 646,395 1.200% | -2,564,954 (-79.87%) | Filing History |
| 2022-02-10 1:58 pm Purchase | 2021-12-31 | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 3,032,727 5.640% | 3,032,727 (New Position) | Filing History |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | Emergent BioSolutions Inc. EBS | VANGUARD GROUP INC | 5,362,031 9.970% | -54,813 (-1.01%) | Filing History |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 8,076,901 15.000% | 0 (Unchanged) | Filing History |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 8,076,901 15.000% | 2,713,394 (+50.59%) | Filing History |
| 2021-12-09 1:54 pm Purchase | 2021-11-30 | 13G | Emergent BioSolutions Inc. EBS | VANGUARD GROUP INC | 5,416,844 10.070% | 626,271 (+13.07%) | Filing History |
| 2021-03-09 6:37 pm Purchase | 2021-02-28 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 5,363,507 10.100% | 86,559 (+1.64%) | Filing History |
| 2021-02-12 08:49 am Purchase | 2020-12-31 | 13G | Emergent BioSolutions Inc. EBS | NEUBERGER BERMAN GROUP LLC | 3,211,349 6.060% | 3,211,349 (New Position) | Filing History |
| 2021-02-10 10:52 am Purchase | 2020-12-31 | 13G | Emergent BioSolutions Inc. EBS | VANGUARD GROUP INC | 4,790,573 9.040% | 123,327 (+2.64%) | Filing History |
| 2021-01-29 09:56 am Sale | 2020-12-31 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 5,276,948 9.950% | -1,543,320 (-22.63%) | Filing History |